Search Results - "Casanovas i Casanovas, Oriol"
-
1
Unraveling the Role of Angiogenesis in Cancer Ecosystems
Published in Frontiers in oncology (02-07-2018)“…Activation of the tumor and stromal cell-driven angiogenic program is one of the first requirements in the tumor ecosystem for growth and dissemination. The…”
Get full text
Journal Article -
2
ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…OBJECTIVE—ALK1 (activin-receptor like kinase 1) is an endothelial cell-restricted receptor with high affinity for BMP (bone morphogenetic protein) 9 TGF-β…”
Get full text
Journal Article -
3
The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
Published in International journal of cancer (15-10-2016)“…In a search for new therapeutic targets for treating epithelial ovarian cancer, we analyzed the Transforming Growth Factor Beta (TGFβ) signaling pathway in…”
Get full text
Journal Article -
4
Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility
Published in Nature communications (16-11-2018)“…Angiogenesis is a dynamic process relying on endothelial cell rearrangements within vascular tubes, yet the underlying mechanisms and functional relevance are…”
Get full text
Journal Article -
5
Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
Published in Cell reports (Cambridge) (10-05-2016)“…Antiangiogenic drugs are used clinically for treatment of renal cell carcinoma (RCC) as a standard first-line treatment. Nevertheless, these agents primarily…”
Get full text
Journal Article -
6
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Published in Nature communications (31-07-2015)“…Coordinated activity of VEGF and Notch signals guides the endothelial cell (EC) specification into tip and stalk cells during angiogenesis. Notch activation in…”
Get full text
Journal Article -
7
Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors
Published in Clinical cancer research (01-12-2016)“…Mutations in the PI3K pathway occur in 16% of patients with pancreatic neuroendocrine tumors (PanNETs), which suggests that these tumors are an exciting…”
Get full text
Journal Article -
8
Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis
Published in The Journal of experimental medicine (23-09-2013)“…Understanding the direct, tumor cell-intrinsic effects of PI 3-kinase (PI3K) has been a key focus of research to date. Here, we report that cancer…”
Get full text
Journal Article -
9
The PDGFRβ-AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
Published in Clinical cancer research (01-02-2014)“…We examined whether PI3K-AKT or extracellular signal-regulated kinase (ERK) signaling pathways could play a role in the development of cisplatin (CDDP)…”
Get full text
Journal Article -
10
Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility
Published in Nature communications (16-11-2018)“…Angiogenesis is a dynamic process relying on endothelial cell rearrangements within vascular tubes, yet the underlying mechanisms and functional relevance are…”
Get full text
Journal Article -
11
ALK1 loss results in vascular hyperplasia in mice and humans through PI3K activation
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…Objective: ALK1 (activin-receptor like kinase 1) is an endothelial cell-restricted receptor with high affinity for BMP (bone morphogenetic protein) 9…”
Get full text
Journal Article -
12
ALK1 loss results in vascular hyperplasia in mice and humans through PI3K activation
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…Objective: ALK1 (activin-receptor like kinase 1) is an endothelial cell-restricted receptor with high affinity for BMP (bone morphogenetic protein) 9…”
Get full text
Journal Article -
13
Therapeutic benefit of selective inhibition of p110α PI3-kinase in pancreatic neuroendocrine tumors
Published in Clinical cancer research (01-12-2016)“…Purpose: mutations in the PI3K pathway occur in 16% of patients with pancreatic neuroendocrine tumors (PanNETs), which suggests that these tumors are an…”
Get full text
Journal Article -
14
Meetronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells
Published in International journal of cancer (15-11-2013)“…In this article, the effectiveness of a multi-targeted chemo-switch (C-S) schedule that combines metronomic chemotherapy (MET) after treatment with the maximum…”
Get full text
Journal Article -
15
Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors
Published in Clinical cancer research (15-05-2009)“…Purpose: Germ cell tumors (GCT) of the testis are highly curable, but those patients who are refractory to cisplatin (CDDP)-based combination chemotherapy have…”
Get full text
Journal Article -
16
The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors
Published in Clinical cancer research (01-02-2014)“…Purpose: we examined whether PI3K-AKT or extracellular signal-regulated kinase (ERK) signaling pathways could play a role in the development of cisplatin…”
Get full text
Journal Article -
17
The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors
Published in Clinical cancer research (01-02-2014)“…Purpose: we examined whether PI3K-AKT or extracellular signal-regulated kinase (ERK) signaling pathways could play a role in the development of cisplatin…”
Get full text
Journal Article -
18
Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
Published in BMC cancer (10-08-2013)“…Cisplatin (CDDP) resistance in testicular germ cell tumors (GCTs) is still a clinical challenge, and one associated with poor prognosis. The purpose of this…”
Get full text
Journal Article -
19
Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis
Published in The Journal of experimental medicine (16-09-2013)“…Understanding the direct, tumor cell–intrinsic effects of PI 3-kinase (PI3K) has been a key focus of research to date. Here, we report that cancer…”
Get full text
Journal Article -
20
Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model
Published in Molecular cancer therapeutics (01-03-2008)“…Gemcitabine shows a marked antitumor effect as a result of its cytotoxic action toward proliferative cells. In this article, we aim to investigate the…”
Get full text
Journal Article